Unveiling the therapeutic potential of miR ‐146a: Targeting innate inflammation in atherosclerosis
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Azizah Puspitasari Ardinal und 2 weiteren Autor:innen. Beteiligte Einrichtung: King's College London School of Cardiovascular and Metabolic Medicine, London, UK. Hauptthemen laut MEDLINE: MicroRNAs, Atherosclerosis, Inflammation, Immunity, Innate. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atherosclerosis is the foremost vascular disease, precipitating debilitating complications. Although therapeutic strategies have historically focused on reducing cholesterol deposition, recent insights emphasize the pivotal role of inflammation. Innate inflammation significantly contributes to plaque instability and rupture, underscoring the need for intervention across all disease stages. Numerous studies have highlighted the therapeutic potential of targeting innate immune pathways in atherosclerosis, revealing significant advancements in understanding the molecular mechanisms underlying inflammatory processes within arterial lesions. Notably, research has demonstrated that the modulation of microRNA‐146a (miR‐146a) expression impacts innate inflammation, effectively halts atherosclerosis progression, and enhances plaque stability by targeting interleukin‐1 receptor‐associated kinase (IRAK) and activating TNF receptor‐associated factor 6 (TRAF6), a signalling pathway involving toll‐like receptors (TLRs). Understanding the intricate mechanisms involved is crucial. This study provides a comprehensive analysis of the evidence and underlying mechanisms through which miR‐146a exerts its effects. Integrating these findings into clinical practice may herald a transformative era in managing atherosclerotic cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- King's College London School of Cardiovascular and Metabolic Medicine, London, UK.
- Bandung City Regional General Hospital, Bandung, Indonesia.
ORCID-Profile: Azizah Puspitasari Ardinal, Alice Valeria Wiyono, Reza Ishak Estiko
Zitieren
APA
Ardinal, A. P., Wiyono, A. V., & Estiko, R. I. (2024). Unveiling the therapeutic potential of miR ‐146a: Targeting innate inflammation in atherosclerosis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70121
Vancouver
Ardinal AP, Wiyono AV, Estiko RI. Unveiling the therapeutic potential of miR ‐146a: Targeting innate inflammation in atherosclerosis. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70121
BibTeX
@article{Ardinal2024,
author = {Ardinal, Azizah Puspitasari and Wiyono, Alice Valeria and Estiko, Reza Ishak},
title = {Unveiling the therapeutic potential of miR ‐146a: Targeting innate inflammation in atherosclerosis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70121}
}
EUVIMED